Story perspectives

Eight Charged in Global Insider Trading Scheme

11/19/2025

37 4

Summary

Story summary

On November 18, 2025, U.S. prosecutors charged eight men in a global insider-trading network active 2016–2024.
The scheme was led by Samy Khouadja (former Merrill Lynch banker), Eamma Safi (co-owner), and Singaporean Zhi Ge, who faces extradition.
They recruited corporate insiders to obtain confidential information about public companies using encrypted messaging.
AstraZeneca's $39 billion purchase of Alexion Pharmaceuticals is cited in the indictment.

1 of 1

Story summary

On November 18, 2025, U.S. prosecutors charged eight men in a global insider-trading network active 2016–2024.
The scheme was led by Samy Khouadja (former Merrill Lynch banker), Eamma Safi (co-owner), and Singaporean Zhi Ge, who faces extradition.
They recruited corporate insiders to obtain confidential information about public companies using encrypted messaging.
AstraZeneca's $39 billion purchase of Alexion Pharmaceuticals is cited in the indictment.